Arkolith/Insider Trading/IGXT/Form 4

ATAI Life Sciences N.V.

10% OwnerIntelGenx Technologies Corp. (IGXT) · full profile →Form 4 · filed Mar 12, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 8, 2024Other(J)4.0M——4.0M
Mar 8, 2024Other(J)1.0M——9.5M
Nov 28, 2023Buy(P)4.1M——16.1M
Nov 28, 2023Buy(P)750K——3.0M
Oct 6, 2023Other(J)8.5M——8.5M
Sep 30, 2023Other(J)7K——7K

Transaction Codes

J
Other acquisition / disposition
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-030437) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML